Description
Research has shown the following potential benefits:
Enhancing immune function
- Boosts T-cell function: TA-1 promotes the maturation and differentiation of T-cells, which are critical white blood cells for the adaptive immune response.
- Modulates immune responses: The peptide can help balance an overactive or underactive immune system. It can upregulate immune responses to fight infections and downregulate them to manage chronic inflammation in autoimmune conditions.
- Activates immune cells: TA-1 can stimulate other immune cells, including dendritic cells, natural killer (NK) cells, and macrophages, to improve the body’s defense against pathogens.
Supporting infectious disease treatment
- Used for hepatitis: The synthetic form of TA-1 (thymalfasin) is approved in dozens of countries for treating hepatitis B and C. It has been shown to improve treatment outcomes when used alongside standard therapies.
- Investigated for sepsis: Research shows TA-1 can help regulate the immune system during sepsis, a life-threatening condition where the immune system overreacts to an infection.
- Explored for other infections: TA-1 has been investigated as an immune enhancer in treating a variety of infections, including HIV, as well as complications from COVID-19. However, studies on its effectiveness for COVID-19 have produced inconsistent results



